News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
33 Results
33 Results
Insights from RECOVER’s pediatric study can inform future clinical trials
Findings from RECOVER’s pediatric observational study are an important first step toward including children in Long COVID clinical trials.
Feature
First webinar of Long COVID treatment initiative highlights early progress
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
News Release
NIH to share RECOVER-TLC updates during November 21 webinar
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
Announcement
NIH invites public participation to inform future Long COVID clinical trials
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Feature
RECOVER-ENERGIZE enrolls first clinical trial participant
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
Feature
Long COVID clinic provides access to research studies and care for University of New Mexico patients
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Feature
NIH to open Long COVID clinical trials to study sleep disturbances, exercise intolerance, and post-exertional malaise
RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.
News Release
NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction
RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
News Release